Citation

BibTex format

@article{Klimek:2026:10.1111/all.70366,
author = {Klimek, L and Mullol, J and Reitsma, S and van, Gerven L and Maza-Solano, J and Lundberg, M and Becker, S and B盲rhold, F and Gawlik, R and Sokolowska, M and Hagemann, J and Akdis, C and Hox, V and Toppila-Salmi, S and Adcock, IM and Escribese, GM and Palomares, O and Moreira, A and Bonadonna, P and Ollert, M and Bousquet, J and de, Corso E and Shamji, M and Jaen, MJT and Arasi, S},
doi = {10.1111/all.70366},
journal = {Allergy},
title = {Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.},
url = {http://dx.doi.org/10.1111/all.70366},
year = {2026}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Klimek,L
AU  - Mullol,J
AU  - Reitsma,S
AU  - van,Gerven L
AU  - Maza-Solano,J
AU  - Lundberg,M
AU  - Becker,S
AU  - B盲rhold,F
AU  - Gawlik,R
AU  - Sokolowska,M
AU  - Hagemann,J
AU  - Akdis,C
AU  - Hox,V
AU  - Toppila-Salmi,S
AU  - Adcock,IM
AU  - Escribese,GM
AU  - Palomares,O
AU  - Moreira,A
AU  - Bonadonna,P
AU  - Ollert,M
AU  - Bousquet,J
AU  - de,Corso E
AU  - Shamji,M
AU  - Jaen,MJT
AU  - Arasi,S
DO  - 10.1111/all.70366
PY  - 2026///
TI  - Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.
T2  - Allergy
UR  - http://dx.doi.org/10.1111/all.70366
UR  - https://www.ncbi.nlm.nih.gov/pubmed/42033170
ER  -
Download

Our Section is involved in

Public Engagement
Find out about past and present activities